TY - JOUR
T1 - Interaction of platelet factor 4 with human platelets
AU - Capitanio, Anna M.
AU - Niewiarowski, Stefan
AU - Rucinski, Boguslaw
AU - Tuszynski, George P.
AU - Cierniewski, Czeslaw S.
AU - Hershock, Diane
AU - Kornecki, Elizabeth
N1 - Funding Information:
This study was supported in part by N.I.H. grants HL-14217, HL-15226, HL-28149 and by the American Heart Association Special Investiga-torship (to E.K.). We wish to thank Dr. U. Lin-dahl for his generous gift of highly purified heparin and Dr. J.C. Holt for providing human platelet factor 4 and fl-thromboglobulin. The participation of Mr. Thomas Morinelli and Ms. Laura Slap in some experiments is greatly appreciated.
PY - 1985/4/17
Y1 - 1985/4/17
N2 - Human washed resting platelets bound 125I-labeled platelet factor 4 in a reaction which was saturable and approached equilibrium within 15-30 min. Scatchard plot analysis of the binding isotherms suggested a single class of specific binding sites. Excess of unlabeled protein and low- and high-affinity heparin competed for platelet factor 4 binding sites on the platelet surface and caused a partial displacement of this molecule. Anti-platelet factor 4 Fab fragments caused inhibition of binding of 125I-platelet factor 4 to platelets. Most of the labeled platelet factor 4 which was bound to intact platelets was recovered in the Triton X-100-insoluble cytoskeletal fraction prepared from the same platelets after their stimulation by thrombin. The association with the cytoskeleton was inhibited by anti-platelet factor 4 Fab fragments and by low-affinity heparin. Anti-platelet factor 4 125I-labeled Fab fragments bound to resting platelets, and this binding was greatly increased following platelet stimulation with thrombin. This suggested that endogenously secreted platelet factor 4 also binds to the platelet surface. No significant binding to platelets of 125I-labeled β-thromboglobulin and 125I-labeled anti-β-thromboglobulin Fab fragments was observed. Fab fragments of monospecific anti-human platelet factor 4 antibody raised in rabbits inhibited platelet aggregation and secretion induced by low concentrations of thrombin. Fab fragments of anti-β-thromboglobulin antibody had no inhibitory effect. We suggest that the binding of α-granule-derived platelet factor 4 to the specific sites on the surface of platelets may modulate platelet gregation and secretion induced by low levels of platelet agonists.
AB - Human washed resting platelets bound 125I-labeled platelet factor 4 in a reaction which was saturable and approached equilibrium within 15-30 min. Scatchard plot analysis of the binding isotherms suggested a single class of specific binding sites. Excess of unlabeled protein and low- and high-affinity heparin competed for platelet factor 4 binding sites on the platelet surface and caused a partial displacement of this molecule. Anti-platelet factor 4 Fab fragments caused inhibition of binding of 125I-platelet factor 4 to platelets. Most of the labeled platelet factor 4 which was bound to intact platelets was recovered in the Triton X-100-insoluble cytoskeletal fraction prepared from the same platelets after their stimulation by thrombin. The association with the cytoskeleton was inhibited by anti-platelet factor 4 Fab fragments and by low-affinity heparin. Anti-platelet factor 4 125I-labeled Fab fragments bound to resting platelets, and this binding was greatly increased following platelet stimulation with thrombin. This suggested that endogenously secreted platelet factor 4 also binds to the platelet surface. No significant binding to platelets of 125I-labeled β-thromboglobulin and 125I-labeled anti-β-thromboglobulin Fab fragments was observed. Fab fragments of monospecific anti-human platelet factor 4 antibody raised in rabbits inhibited platelet aggregation and secretion induced by low concentrations of thrombin. Fab fragments of anti-β-thromboglobulin antibody had no inhibitory effect. We suggest that the binding of α-granule-derived platelet factor 4 to the specific sites on the surface of platelets may modulate platelet gregation and secretion induced by low levels of platelet agonists.
UR - http://www.scopus.com/inward/record.url?scp=0021796294&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021796294&partnerID=8YFLogxK
U2 - 10.1016/0304-4165(85)90033-9
DO - 10.1016/0304-4165(85)90033-9
M3 - Article
C2 - 4039192
AN - SCOPUS:0021796294
SN - 0304-4165
VL - 839
SP - 161
EP - 173
JO - BBA - General Subjects
JF - BBA - General Subjects
IS - 2
ER -